Vedolizumab was safe and showed superiority over infliximab as first-line biologic therapy in the management of patients with UC.

Patients with inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) show promising outcomes when receiving advanced therapies following liver transplantation, according to study ...

Hidradenitis suppurativa is more common among patients with Crohn disease (CD) than ulcerative colitis (UC), yet bowel obstruction affects both CD and UC.

Mail-order stool kits may help patients with IBD complete testing, improving adherence for disease monitoring. Due to a reported “positive experience,” more than 90% of patients with inflammatory ...

Researchers confirmed the long-term safety profile of ozanimod for the treatment of moderate to severe UC or RMS.

Risankizumab for Crohn disease taken over a long-term extension results in clinically meaningful sustained HRQOL improvements.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Ileosigmoid fistulas in Crohn disease are surgically managed in varying ways, which suggests a need for standardized guidelines.

Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

Overall survival at 5 years for individuals who received a liver transplant for certain cancers is deemed adequate.

During pregnancy, women should receive recommended COVID-19 vaccines to protect themselves, as well as their young infants.

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist obesity medications.